Ajax Therapeutics, Inc., a biopharmaceutical company applying computational chemistry and structure-based technologies to develop novel, selective small molecules for myeloproliferative neoplasms (MPNs), announced the...
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., Europe, and additional international markets, announced...
Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, shared initial clinical validation data for its breast cancer radiation signature, Profile...
Blueprint Medicines Corporation announced AYVAKIT data showing high, durable response rates and prolonged overall survival (OS) in patients with advanced systemic mastocytosis (Advanced SM),...
